An In Vitro Combined Antibiotic-Antibody Treatment Eliminates Toxicity from Shiga Toxin-Producing Escherichia coli

C Skinner, G Zhang, S Patfield… - Antimicrobial agents and …, 2015 - Am Soc Microbiol
ABSTRACT Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal
infections is difficult. The utility of antibiotics for STEC treatment is controversial, since …

An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.

C Skinner, G Zhang, S Patfield, X He - Antimicrobial Agents and …, 2015 - europepmc.org
Abstract Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal infections is
difficult. The utility of antibiotics for STEC treatment is controversial, since antibiotic …

An in vitro combined antibiotic/antibody treatment eliminates toxicity from Shiga toxin-producing E. coli

CB Skinner, SA Patfield, X He, G Zhang - Antimicrobial Agents and …, 2015 - ars.usda.gov
Shiga toxins (Stx) are an important virulence factor for Escherichia coli, a common and
potentially deadly bacterial food contaminant. An estimated 100,000 gastrointestinal …

An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.

C Skinner, GD Zhang, S Patfield, XH He - 2015 - cabidigitallibrary.org
Abstract Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal infections is
difficult. The utility of antibiotics for STEC treatment is controversial, since antibiotic …

An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli

C Skinner, G Zhang, S Patfield… - Antimicrobial agents …, 2015 - pubmed.ncbi.nlm.nih.gov
Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal infections is difficult.
The utility of antibiotics for STEC treatment is controversial, since antibiotic resistance …

An In Vitro Combined Antibiotic-Antibody Treatment Eliminates Toxicity from Shiga Toxin-Producing Escherichia coli

C Skinner, G Zhang, S Patfield, X He - Antimicrobial Agents and …, 2015 - cir.nii.ac.jp
抄録< jats: title> ABSTRACT</jats: title>< jats: p> Treating Shiga toxin-producing< jats:
named-content xmlns: xlink=" http://www. w3. org/1999/xlink" content-type=" genus-species" …

[PDF][PDF] An in vitro combined antibiotic

C Skinner, G Zhang, S Patfield, X He - 2015 - Citeseer
MATERIALS AND METHODS E. coli strains and growth conditions. All E. coli strains were
grown in Luria-Bertani (LB) medium (Luria-Bertani broth; Miller, Fisher Scientific). E. coli …

[PDF][PDF] An in vitro combined antibiotic

C Skinner, G Zhang, S Patfield, X He - 2015 - academia.edu
MATERIALS AND METHODS E. coli strains and growth conditions. All E. coli strains were
grown in Luria-Bertani (LB) medium (Luria-Bertani broth; Miller, Fisher Scientific). E. coli …

[HTML][HTML] An In Vitro Combined Antibiotic-Antibody Treatment Eliminates Toxicity from Shiga Toxin-Producing Escherichia coli

C Skinner, G Zhang, S Patfield, X He - Antimicrobial Agents and …, 2015 - ncbi.nlm.nih.gov
Abstract Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal infections is
difficult. The utility of antibiotics for STEC treatment is controversial, since antibiotic …

An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxin-producing Escherichia coli.

C Skinner, G Zhang, S Patfield, X He - Antimicrobial Agents and …, 2015 - europepmc.org
Abstract Treating Shiga toxin-producing Escherichia coli (STEC) gastrointestinal infections is
difficult. The utility of antibiotics for STEC treatment is controversial, since antibiotic …